{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:50:46Z","timestamp":1785775846361,"version":"3.56.0"},"reference-count":22,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T00:00:00Z","timestamp":1118275200000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Many patients treated with a proton\u2010pump inhibitor for gastro\u2010oesophageal reflux disease or erosive oesophagitis still have substantial night\u2010time gastric acidity. A previous trial of a new immediate\u2010release omeprazole oral suspension suggested that nocturnal gastric acidity could be more effectively controlled with a bedtime dose of immediate\u2010release omeprazole than with a delayed\u2010release proton\u2010pump inhibitor administered before dinner or at bedtime.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To compare the ability of immediate\u2010release omeprazole with pantoprazole to control nocturnal gastric acidity, when they were dosed once daily and twice daily.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002Thirty\u2010six patients with nocturnal gastro\u2010oesophageal reflux disease symptoms received immediate\u2010release omeprazole and pantoprazole in this open\u2010label, randomized\u2010crossover trial. Median gastric pH, the percentage of time with gastric pH\u2003&gt;\u20034 and the percentage of patients with nocturnal acid breakthrough, were evaluated with 24\u2010h pH monitoring.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Repeated once daily (bedtime) dosing with immediate\u2010release omeprazole suspension produced significantly better nocturnal gastric acid control than repeated once daily (predinner) or twice daily (prebreakfast and bedtime) dosing with pantoprazole delayed\u2010release tablets (median pH: 4.7 vs. 2.0 and 1.7; percentage of time pH\u2003&gt;\u20034: 55 vs. 27 and 34; nocturnal acid breakthrough: 53 vs. 78 and 75). Twice daily dosing (prebreakfast and bedtime) with immediate\u2010release omeprazole 20 and 40\u2003mg achieved the best night\u2010time control of gastric acidity. Repeated once daily bedtime dosing with immediate\u2010release omeprazole 40\u2003mg and twice daily dosing with pantoprazole 40\u2003mg gave similar 24\u2010h pH control. No safety issues were associated with either drug in this trial.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002Dosed once daily at bedtime, immediate\u2010release omeprazole reduced nocturnal gastric acidity to a degree not observed with once daily dosing of delayed\u2010release proton\u2010pump inhibitors.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2005.02513.x","type":"journal-article","created":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T11:23:20Z","timestamp":1118316200000},"page":"1467-1474","source":"Crossref","is-referenced-by-count":58,"title":["Comparison of the effects of immediate\u2010release omeprazole powder for oral suspension and pantoprazole delayed\u2010release tablets on nocturnal acid breakthrough in patients with symptomatic gastro\u2010oesophageal reflux disease"],"prefix":"10.1111","volume":"21","author":[{"given":"D.","family":"Castell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Goldlust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hepburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,6,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091249"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199611000-00013"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00419.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.221_a.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.14309\/00000434-200410001-00116","article-title":"Nighttime dosing of omeprazole immediate\u2010release oral suspension rapidly decreases nocturnal gastric acidity","volume":"99","author":"Goldlust B","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41217.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07304.x"},{"key":"e_1_2_6_9_2","volume-title":"Acid\u2010related Diseases \u2013 Biology and Treatment","author":"Modlin IM","year":"1998"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00829.x"},{"key":"e_1_2_6_11_2","first-page":"11","article-title":"Nocturnal acid breakthrough \u2013 approach to management","volume":"6","author":"Tutuian R","year":"2004","journal-title":"Med Gen Med"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01949.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70010-1"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01050.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.19.1.19"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07531.x"},{"key":"e_1_2_6_17_2","unstructured":"Food and Drug Administration Website.Label for Prevacid\u00ae. Available at:http:\/\/www.fda.gov\/cder\/foi\/label\/2004\/020406s057_021281s014_021428s004lbl%20.pdf accessed on 8 March 2005."},{"key":"e_1_2_6_18_2","unstructured":"Food and Drug Administration Website.Label for Prilosec\u00ae. Available at:http:\/\/www.fda.gov\/cder\/foi\/label\/2004\/19810se8\u2010058 slr003_prilosec_lbl.pdf accessed on 8 March 2005."},{"key":"e_1_2_6_19_2","unstructured":"Food and Drug Administration Website.Label for Protonix\u00ae. Available at:http:\/\/www.fda.gov\/cder\/foi\/label\/2004\/20987slr020_protonix_lbl.pdf accessed on 8 March 2005."},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","unstructured":"RackoffA AgrawalA HilaA et\u00a0al.Histamine\u20102 receptor antagonists at night improve GERD symptoms for patients on proton pump inhibitor therapy. Proceedings of the 69th ACG Annual Meeting 2004; October 29\u2013November 30 Orlando Florida USA 2004:110.","DOI":"10.14309\/00000434-200410001-00052"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1053\/bega.2001.0190"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(94)94341-9"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000157751.92249.32"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2005.02513.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2005.02513.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T10:52:49Z","timestamp":1697194369000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2005.02513.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1111\/j.1365-2036.2005.02513.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02513.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}